<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791074</url>
  </required_header>
  <id_info>
    <org_study_id>2013/365/C</org_study_id>
    <nct_id>NCT02791074</nct_id>
  </id_info>
  <brief_title>Heart Failure Ventricular Pressure Time Profile</brief_title>
  <acronym>HF-VFM</acronym>
  <official_title>Non-invasive Determination of Intra-left Ventricular Pressure-time Profile for Diagnosis of Heart Failure With Normal and Reduced Ejection Fraction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart Centre Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart Centre Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This proposed study aim to:&#xD;
&#xD;
        1. Determine intra-LV pressure-time profile non-invasively using recently developed echo&#xD;
           Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF&#xD;
           subjects (both HFNEF and HFREF) compared to normal volunteers.&#xD;
&#xD;
        2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure (HF) is a common disease and its syndrome is difficult to diagnose. HF with&#xD;
      reduced ejection fraction (HFREF) may be diagnosed based on impaired LVEF (&lt;50%). However,&#xD;
      diagnosis of HF with normal ejection fraction (HFNEF) is mainly based on the presence of&#xD;
      signs and symptoms.&#xD;
&#xD;
      Central to diagnosis of HF is estimation of intra-cardiac pressure, which can only be&#xD;
      obtained from invasive catheterization.&#xD;
&#xD;
      This proposed study aim to:&#xD;
&#xD;
        1. Determine intra-LV pressure-time profile non-invasively using recently developed echo&#xD;
           Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF&#xD;
           subjects (both HFNEF and HFREF) compared to normal volunteers.&#xD;
&#xD;
        2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>First occurrence of cardiovascular event</measure>
    <time_frame>1 Year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy Volunteers will undergo the following studying procedures:&#xD;
Echocardiography Arterial tonometry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart Failure Patients</arm_group_label>
    <description>Patients will undergo the following studying procedures:&#xD;
NTproBNP Echocardiography Arterial tonometry</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NTproBNP</intervention_name>
    <description>To assess its level in the blood, as a marker of heart failure presence and severity.</description>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>To measure heart chamber size, heart function, blood vessel size and blood vessel function. These measurements will help us understand the type and severity of heart failure.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Arterial tonometry</intervention_name>
    <description>A noninvasive method to obtain arterial pressure waveform.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Heart Failure Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        35 diagnosed heart failure patient will be recruited from primary care clinic, outpatient&#xD;
        clinics and hospital ward from NHCS.&#xD;
&#xD;
        40 Healthy Volunteer control group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Either&#xD;
&#xD;
               1. has presented to hospital with a primary diagnosis of Heart Failure or&#xD;
&#xD;
               2. is attending a hospital clinic for management of Heart Failure within 6 months of&#xD;
                  an episode of decompensated heart failure, which either:&#xD;
&#xD;
                    -  resulted in a hospital admission (primary diagnosis) or&#xD;
&#xD;
                    -  was treated in out-patient clinic&#xD;
&#xD;
          -  LVEF &gt;50% is used as cut-off value for HFNEF and LVEF &lt; 50% for HFREF.&#xD;
&#xD;
          -  NT-proBNP within 7 days of admission &gt; 220pg/ml. If there is no result available,&#xD;
             NT-proBNP on the same day as echo scan must be &gt; 220pg/ml.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Haemodynamically significant valve disease defined as more than mild degree of valve&#xD;
             stenosis, or more than moderate degrees of mitral or aortic valve regurgitation.&#xD;
&#xD;
          -  History of valvular disease, i.e. rheumatic heart disease and/or having undergone&#xD;
             valvular replacement.&#xD;
&#xD;
          -  Isolated right heart failure due to pulmonary disease.&#xD;
&#xD;
          -  Presence of haemodynamically significant obstructive lesions of left ventricular&#xD;
             outflow tract.&#xD;
&#xD;
          -  History of any organ transplant or who was on a transplant list (life expectancy &lt; 6&#xD;
             months at time of enrollment).&#xD;
&#xD;
          -  Presence of end-stage renal failure.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  The patient is unable to provide written informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thu Thao Le, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Centre Singapore</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>May 31, 2016</study_first_submitted>
  <study_first_submitted_qc>May 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2016</study_first_posted>
  <last_update_submitted>March 30, 2017</last_update_submitted>
  <last_update_submitted_qc>March 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

